Hepcidin in iron metabolism

Current Opinion in Hematology

Volumn 11, Issue 4, 2004, Pages 251-254

  Ganz, Tomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepcidin; Iron; Metabolism

Indexed keywords

HEMOGLOBIN; HEPCIDIN;

ANEMIA; CELLULAR IMMUNITY; CHRONIC DISEASE; DRUG MECHANISM; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; INTESTINE ABSORPTION; IRON ABSORPTION; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; MACROPHAGE; NONHUMAN; PLACENTA CIRCULATION; PLACENTAL TRANSFER; PRIORITY JOURNAL; REVIEW;

ANEMIA; ANTIMICROBIAL CATIONIC PEPTIDES; HEMOCHROMATOSIS; HUMANS; IRON;

EID: 4344600507     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200407000-00004     Document Type: Review

References (45)

1. Fleming RE, Sly WS: Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A 2001, 98:8160-8162.
2. Ganz T: The role of hepcidin in iron sequestration during infections and in the pathogenesis of anemia of chronic disease. Isr Med Assoc J 2002, 4:1043-1045.
3. Nicolas G, Viatte L, Bennoun M, et al.: Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002, 29:327-335.
4. Ganz T: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102:783-788. Two comprehensive reviews in English from active contributors to the study of this peptide and its activity.
5. Loreal O, Brissot P: [Hepcidin: small molecule, large future.] Rev Med Interne 2003, 24:213-215.
6. del Castillo RA, de Portugal AJ: [Hepcidin, a new protein of body iron homeostasis.] An Med Interna 2003, 20:605-606.
7. Ashrafian H: Hepcidin: the missing link between hemochromatosis and infections. Infect Immun 2003, 71:6693-6700.
8. Deicher R, Horl WH: Hepcidin: a molecular link between inflammation and anaemia. Nephrol Dial Transplant 2004, 19:521-524.
9. Ioannou GN, Kowdley KV: Hepcidin in HFE-associated hemochromatosis: another piece of the "iron" puzzle. Gastroenterology 2004, 126:615-616.
10. Leong WI, Lonnerdal B: Hepcidin, the recently identified peptide that appears to regulate iron absorption. J Nutr 2004, 134:1-4.
11. Marrif H: Is hepcidin an iron cluster peptide? Med Hypotheses 2004, 62:554-555.
12. Robson KJ: Hepcidin and its role in iron absorption. Gut 2004, 53:617-619.
13. Walker AP, Partridge J, Srai SK, Dooley JS: Hepcidin: what every gastroenterologist should know. Gut 2004, 53:624-627.
14. Andrews NC: Disorders of iron metabolism. N Engl J Med 1999, 341:1986-1995.
15. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001, 276:7806-7810.
16. Krause A, Neitz S, Magert HJ, et al.: LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000, 480:147-150.
17. Pigeon C, Ilyin G, Courseaud B, et al.: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001, 276:7811-7819.
18. Ilyin G, Courselaud B, Troadec MB, et al.: Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload. FEBS Lett 2003, 542:22-26.
19. Lou DQ, Nicolas G, Lesbordes JC, et al.: Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 2004, 103:2816-2821. Despite some similarities in the regulation of hepcidin-1 and 2 by iron, the two forms have different tissue distribution and only hepcidin-1 regulates intestinal iron absorption.
20. Nicolas G, Bennoun M, Devaux I, et al.: Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 2001, 98:8780-8785.
21. Mazur A, Feillet-Coudray C, Romier B, et al.: Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice. Metabolism 2003, 52:1229-1231. Despite its apparent lack of involvement in iron metabolism, hepcidin 2 mRNA levels are also regulated by dietary iron.
22. Hunter HN, Fulton DB, Ganz T, Vogel HJ: The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002, 277:37597-37603.
23. Shike H, Lauth X, Westerman ME, et al.: Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem 2002, 269:2232-2237.
24. Nicolas G, Bennoun M, Porteu A, et al.: Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002, 99:4596-4601.
25. Roetto A, Papanikolaou G, Politou M, et al.: Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003, 33:21-22. A very important article that definitively demonstrates the nonredundant role of hepcidin in human iron metabolism.
26. Weinstein DA, Roy CN, Fleming MD, et al.: Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002:2002-2004.
27. Nicolas G, Chauvet C, Viatte L, et al.: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110:1037-1044.
28. Nemeth E, Valore EV, Territo M, et al.: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003, 101:2461-2463. This article describes the first measurements of hepcidin release in humans as estimated by a urine immunoassay. Hepcidin release is increased during infections, inflammation, and iron overload. In cell culture studies, IL-6 is implicated as a key regulator of hepcidin.
29. Dallalio G, Fleury T, Means RT: Serum hepcidin in clinical specimens. Br J Haematol 2003, 122:996-1000.
30. Courselaud B, Pigeon C, Inoue Y, et al.: C/EBP alpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 2002, 277:41163-41170.
31. Andrews NC: Metal transporters and disease. Curr Opin Chem Biol 2002, 6:181-186.
32. Anderson GJ, Frazer DM, Wilkins SJ, et al.: Relationship between intestinal iron-transporter expression, hepatic hepcidin levels and the control of iron absorption. Biochem Soc Trans 2002, 30:724-726.
33. Frazer DM, Wilkins SJ, Becker EM, et al.: Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002, 123:835-844. These two articles demonstrate that the time course and direction of changes in hepcidin expression is consistent with its proposed role as a regulator of iron transport molecules.
34. Laftah AH, Ramesh B, Simpson RJ, et al.: Effect of hepcidin on intestinal iron absorption in mice. Blood 2004, 103:3940-3944. This is the first reported attempt to test the effects of synthetic hepcidin in experimental animals. Despite the impurity of the hepcidin preparation, a clear inhibitory effect on intestinal iron transport was observed.
35. Ahmad KA, Ahmann JR, Migas MC, et al.: Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 2002, 29:361-366.
36. Bridle KR, Frazer DM, Wilkins SJ, et al.: Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003, 361:669-673.
37. Gehrke SG, Kulaksiz H, Herrmann T, et al.: Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 2003, 102:371-376.
38. Muckenthaler M, Roy CN, Custodio AO, et al.: Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet 2003, 34:102-107. These four articles demonstrate that hepcidin expression is inappropriately low in HFE-deficient hemochromatosis of humans and mice.
39. Nicolas G, Viatte L, Lou DQ, et al.: Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003, 34:97-101. This elegant study demonstrates that transgenic hepcidin-1 expression corrects the increased absorption of iron in mice with disrupted HFE.
40. Papanikolaou G, Samuels ME, Ludwig EH, et al.: Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004, 36:77-82. This important article presented the first evidence that homozygous mutations in the newly recognized hemojuvelin gene are the cause of most cases of juvenile hemochromatosis, with the remainder due to homozygous mutations in the hepcidin gene. Patients with juvenile hemochromatosis due to hemojuvelin mutations have very low hepcidin excretion suggesting that hemojuvelin normally acts as a regulator of hepcidin.
41. Lanzara C, Roetto A, Daraio F, et al.: The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 2004, Feb 24 [epub ahead of print].
42. Lee PL, Beutler E, Rao SV, Barton JC: Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood 2004, Feb 24 [epub ahead of print]. These two articles present confirmatory evidence that homozygous hemojuvelin mutations are responsible for juvenile hemochromatosis.
43. Nicolas G, Andrews NC, Kahn A, Vaulont S: Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice. Blood 2004, 103:2841-2843.
44. Merryweather-Clarke AT, Cadet E, Bomford A, et al.: Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 2003, 12:2241-2247. In mice and humans respectively, these two articles show that heterozygosity for disruptive hepcidin mutations worsens iron overload in HFE hemochromatosis.
45. Cartwright GE: The anemia of chronic disorders. Semin Hematol 1966, 3:351-375.